EGFR and lung adenocarcinoma: For example, Zhang et al. [44] constructed a clinical-radiological-radiomics model (C-R-R), based on the combination of CT radiomics feature signature with clinical and radiological features, aiming to predict epidermal growth factor receptor (EGFR) status among 420 patients with lung adenocarcinoma.